Atherosclerosis is a form of arterial disease that manifests in the coronary circulation as
coronary artery disease (CAD), in the carotid arteries as cerebrovascular disease, and in the …

The atherothrombotic conditions, coronary artery disease, cerebrovascular disease and
peripheral arterial disease (PAD), together account for almost one-half of all deaths in …

Objective To determine cardiovascular comorbidities and use of cardiovascular disease
preventive drugs in patients with peripheral arterial disease (PAD), with special attention to …

(8, 9). Therefore, PAD should be treated to achieve the appropriate NCEP ATP III low-
density lipoprotein cholesterol (LDL-C) target of 70 to 100 mg/dL (1.8–2.6 mmol/L)(8, 9) …

Background The role of lipoproteins as markers of peripheral arterial disease (PAD) is not
well defined. Methods We measured both lipid and non-lipid risk factors in 51 male patients …

Although peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis, the
heightened cardiovascular risk in these patients has been consistently under-recognized by …

OBJECTIVES: Peripheral artery disease (PAD) is an atherosclerotic disease associated with
cardiovascular risk factors, and with high cardiovascular morbidity and mortality. This study …

Objective The purpose of this study was to analyze the results of the ATTEST study in order
to evaluate general medicine management practices for peripheral arterial disease (PAD) …

This paper reviews the current epidemiological data on peripheral artery disease (PAD) in
Europe. Cardiovascular disease (CVD) burden is presented and PAD prevalence is …

The epidemiology of peripheral arterial disease (PAD) has been studied almost exclusively
in northern European and northern American populations. We report the first survey in Italy …